{"id":"W2131166024","doi":"10.1007/s003840100285","title":"Use of anti-tumour necrosis factor agents in inflammatory bowel disease","year":2001,"lang":"en","type":"article","venue":"International Journal of Colorectal Disease","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Ontario Tech University","funders":"United European Gastroenterology","keywords":"Infliximab; Medicine; Adalimumab; Intensive care medicine; Grading (engineering); Disease; Inflammatory bowel disease; Clinical trial; Certolizumab pegol; Hepatology; MEDLINE; Etanercept; Crohn's disease; Internal medicine; Tumor necrosis factor alpha; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001371246,0.0002018004,0.0001778858,0.0002709915,0.0000268899,0.00006828087,0.000504485,0.00007057517,0.000169616],"category_scores_gemma":[0.0007013302,0.0001986752,0.0003364135,0.00007384678,0.0001168799,0.000069369,0.0001480244,0.0001301667,0.0000102927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000831049,"about_ca_system_score_gemma":0.0005001079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008143568,"about_ca_topic_score_gemma":0.00001463992,"domain_scores_codex":[0.9981667,0.0001177378,0.0006756139,0.0002164588,0.0006009554,0.0002224767],"domain_scores_gemma":[0.9981911,0.00002906899,0.0004735538,0.0001865601,0.0005929749,0.0005267379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007321969,0.0004709762,0.9470848,0.00002784127,0.0001634521,0.003285296,0.00004128193,0.00272736,0.03779184,0.00006289183,0.0007633945,0.0002588306],"study_design_scores_gemma":[0.001278694,0.00006697615,0.9936866,0.0001063652,0.00004395521,0.00002029655,0.00001385923,0.0005169021,0.002344093,0.0001412439,0.00158944,0.0001916137],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984965,0.0001722013,0.00004497887,0.0001836683,0.0006106374,0.0001740669,0.000256016,0.000006064428,0.00005581889],"genre_scores_gemma":[0.9989733,0.0002551276,0.0000715983,0.0002360041,0.0002545203,0.000009876706,0.00006430873,0.00002809303,0.0001071446],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0466017,"threshold_uncertainty_score":0.8101741,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01724662855306872,"score_gpt":0.272653483049452,"score_spread":0.2554068544963833,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}